Human elongation factor 1 alpha short form (EFS) promoter

Compact ubiquitous constitutive promoter derived from a truncation of full-length EF1α, retaining stable long-term expression with significantly lower epigenetic silencing than CMV in dividing cells and in vivo. Widely used in size-constrained vectors including AAV and lentiviral systems.

Length: 232 bp

Strength: Moderate constitutive

Characteristics

Compact ~212 bp truncated version of EF1α; ubiquitous but weaker than full-length EF1α. Widely used in cargo-limited AAV and lentiviral vectors where size is a constraint.

Applications: Ideal for AAV applications where promoter size matters. Maintains stable expression over months. Good balance of strength and longevity for chronic disease models.

Sequence

You must be signed in to view the full sequence.

Sign in / Register

References

  1. Kim et al. (1990). Use of the human elongation factor 1 alpha promoter as a versatile and efficient expression system. Gene - Kim 1990 EF1a Promoter